Nurix Therapeutics Doses First Patient in Phase 1 Clinical Trial of DeTIL-0255, a Drug-Enhanced Cell Therapy for the Treatment of Patients with Solid Tumors
First in human study of drug-enhanced tumor infiltrating lymphocyte therapy in patients with gynecological malignanciesSAN FRANCISCO, April 05, 2022 (GLOBE...
2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement